Crystalline paroxetine methane sulfonate

Details Crystalline paroxetine methane sulfonate Crystalline paroxetine methane sulfonate

1998-11-30

2009-10-06

Chang, Celia (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S317000, C514S319000, C546S197000, C546S198000, C546S205000, C546S206000, C546S236000

Reexamination Certificate

active

07598271

ABSTRACT:
The invention relates to a compound, and pharmaceutically acceptable salts, having the formula I:wherein:R represents an alkyl or alkynyl group having 1-4 carbon atoms, or a phenyl group optionally substituted by C1-4alkyl, alkylthio, alkoxy, halogen, nitro, acylamino, methylsulfonyl or methylenedioxy, or represents tetrahydronaphthyl,R1represents hydrogen, trifluoro (C1-4) alkyl, alkyl or alkynyl,X represents hydrogen, alkyl having 1-4 carbon atoms, alkoxy, trifluoroalkyl, hydroxy, halogen, methylthio or aralkoxy,R2represents:a C1-C10 alkyl group,a phenyl group optionally substituted by one or more of the following groups:a C1-C10 alkyl group,a halogen group,a nitro group,hydroxy group,and/or an alkoxy group.

REFERENCES:
patent: 3912743 (1975-10-01), Christensen et al.
patent: 4007196 (1977-02-01), Christensen et al.
patent: 4585777 (1986-04-01), Lassen et al.
patent: 4721723 (1988-01-01), Barnes et al.
patent: 4902801 (1990-02-01), Faruk et al.
patent: 5258517 (1993-11-01), Zepp et al.
patent: 5276042 (1994-01-01), Crenshaw et al.
patent: 5371092 (1994-12-01), Johnson
patent: 5668134 (1997-09-01), Klimstra et al.
patent: 5955475 (1999-09-01), Krape et al.
patent: 99 678 2 (1988-09-01), None
patent: 2143070 (1995-08-01), None
patent: 2187128 (1997-06-01), None
patent: 2404113 (1974-08-01), None
patent: 19603797 (1996-08-01), None
patent: 0 188 081 (1986-07-01), None
patent: 0 190 496 (1986-08-01), None
patent: 0 219 934 (1987-04-01), None
patent: 0 223 334 (1987-05-01), None
patent: 0 223 403 (1987-05-01), None
patent: 0 266 574 (1988-05-01), None
patent: 0 269 303 (1988-06-01), None
patent: 0 300 617 (1989-01-01), None
patent: 0 374 674 (1990-06-01), None
patent: 0 374 675 (1990-06-01), None
patent: 0 600 714 (1994-06-01), None
patent: 0 714 663 (1996-06-01), None
patent: 0 802 185 (1997-10-01), None
patent: 0 810 224 (1997-12-01), None
patent: 0 810 225 (1997-12-01), None
patent: 0 812 827 (1997-12-01), None
patent: 1 422 263 (1976-01-01), None
patent: 179187 (1974-08-01), None
patent: WO 92/09281 (1992-06-01), None
patent: WO 93/22284 (1993-11-01), None
patent: WO 94/03428 (1994-02-01), None
patent: WO 95/15155 (1995-06-01), None
patent: WO 95/16448 (1995-06-01), None
patent: WO 95/20964 (1995-08-01), None
patent: WO 96/24595 (1996-08-01), None
patent: WO 96 31197 (1996-10-01), None
patent: WO 96/36636 (1996-12-01), None
patent: WO 97/03670 (1997-02-01), None
patent: WO 97/18798 (1997-05-01), None
patent: WO 97/24323 (1997-07-01), None
patent: WO 97/31915 (1997-09-01), None
patent: WO 98/01424 (1998-01-01), None
Berge et al. “Pharmaceutical salts” J. Pharm. Sci. v.66, p. 1-18, 1977.
Opinion 2005 UKHL 59 of the UK House of Lords of Appeal,Synthon BV(Appellants) v.Smithkline Beecham plc(Respondents), Oct. 20, 2005 (28 pgs.).

Affiliated with

Also associated with

Rating

Crystalline paroxetine methane sulfonate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline paroxetine methane sulfonate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline paroxetine methane sulfonate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4054454